Medication info
Sitagliptin 50 mg Tablets (Sitagliptin Hydrochloride Hydrate)

Sitagliptin 50 mg Tablets (Sitagliptin Hydrochloride Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Sitagliptin Hydrochloride Hydrate›56.69mg / 1 tablet
Manufacturer / importer
Genewell Science Co., Ltd.
Appearance
Round film-coated tablet of bright light yellow-pink color
Packaging
30 tablets per bottle, 100 tablets per bottle
Approval status
Active

MFDS item code 202007523 · Approved 2020.11.03 · Insurance code 671706670

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
This medicine is administered at 100 mg once daily, either as monotherapy or in combination therapy; the maximum daily dose is 100 mg. This medicine may be taken with or without food. When administered in combination with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions, 5. General precautions). Patients with renal impairment Since dose adjustment is required according to renal function, assessment of renal function is recommended before and periodically after starting this medicine. 1. No dose adjustment is required for patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is required for patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily to patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily to patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medicine may be administered regardless of the timing of dialysis.

Ingredients

Manufacturer
Genewell Science Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Abnormal blood glucose control in patients with type 2 diabetes
View approved original text

This medication assists in controlling blood glucose levels in patients with type 2 diabetes by complementing dietary and exercise therapy. It can be used alone or in combination with other treatments for tailored patient care. This helps effectively manage blood glucose levels.

How to take

Adult dose

This medicine is administered at 100 mg once daily, either as monotherapy or in combination therapy; the maximum daily dose is 100 mg. This medicine may be taken with or without food. When administered in combination with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions, 5. General precautions). Patients with renal impairment Since dose adjustment is required according to renal function, assessment of renal function is recommended before and periodically after starting this medicine. 1. No dose adjustment is required for patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is required for patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily to patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily to patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medicine may be administered regardless of the timing of dialysis.

Precautions

This medication may cause allergic reactions, so if symptoms such as skin rash or difficulty breathing occur, discontinue use immediately and consult a physician. While taking this medication, there is a risk of developing serious pancreatic inflammation known as pancreatitis; therefore, if symptoms such as abdominal pain, vomiting, or loss of appetite occur, inform healthcare professionals immediately. This medication should not be used in patients with type 1 diabetes or diabetic ketoacidosis. Patients with decreased kidney function may need dosage adjustments, and regular kidney function tests are recommended. While taking this medication, side effects such as cold symptoms, headache, indigestion, and diarrhea may occur; consult a physician if symptoms are severe or persistent. When taken with other blood glucose-lowering drugs, especially insulin or sulfonylureas, the risk of hypoglycemia may increase, so blood glucose levels should be monitored closely. If severe joint pain or skin blistering occurs, discontinue use immediately and inform healthcare professionals. Pregnant or breastfeeding women are advised not to take this medication, and safety and efficacy have not been established for children under 18 years of age. Elderly patients may have decreased kidney function, so dosage adjustments and regular kidney function tests are necessary. In case of overdose, seek immediate medical attention for appropriate treatment, as some medications can be removed by dialysis.

Side effects

Severe hypersensitivity reactions, anaphylaxis, angioedema, Stevens-Johnson syndrome, exfoliative skin disease, acute pancreatitis, hypoglycemia, upper respiratory infection, nasopharyngitis, headache, diarrhea, abdominal pain, nausea, constipation, vomiting, severe and disability-associated arthralgia, vesicular pemphigoid, myalgia, limb pain, back pain, interstitial lung disease, pruritus, thrombocytopenia, rhabdomyolysis, elevated liver enzymes, acute kidney failure, pneumonia, diabetes complications, metabolic acidosis, falls, cardiac arrest, dyspepsia, dizziness, increased serum triglycerides, gastritis, weight loss, hypertension, hypernatremia, erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to keep out air. The recommended storage temperature is between 1 and 30 degrees Celsius at room temperature. This helps maintain the effectiveness of the medication for a long time.

Appearance and packaging

Appearance

Round film-coated tablet of bright light yellow-pink color

Package unit

30 tablets per bottle, 100 tablets per bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.